telehealth glp-1 medication nutrition coaching lab tracking Nutritional priorities to support therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society - MEDVi is showing what a

It enhances glucose-dependent insulin secretion, suppresses glucagon, and slows gastric emptying key mechanisms for glucose control

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been pivotal for obesity treatment, achieving 1525 % weight loss over 1224 months, but questions remain about the potential influence of concomitant losses in muscle mass

GLP-1 medications have become increasingly common, but as more and more of these prescriptions enter households, the risk of accidental pet exposure has also grown

Learn what to do as Aetna exits the ACA Marketplace in 2026

GLP-1 Receptor Agonists and Thyroid Cancer Risk: What the Evidence Really Shows As GLP-1RAs revolutionise diabetes and obesity treatment, concerns about thyroid cancer persist

Lets get ready to rumble